Cargando…

Editorial: Immunomodulatory factors, conversion, and postoperative adjuvant therapy for hepatobiliary tumors based on immunotherapy

Detalles Bibliográficos
Autor principal:	Zhang, Er-lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242167/ https://www.ncbi.nlm.nih.gov/pubmed/37287965 http://dx.doi.org/10.3389/fimmu.2023.1218845

Ejemplares similares

Editorial: Immunological characteristics of malignant tumors of the hepatobiliary system and identification of immunotherapy targets
por: Zhang, Qiyao, et al.
Publicado: (2023)

Editorial: Studying novel immune signatures, targets, and drugs in hepatobiliary tumors: based on advanced technologies
por: Xuan, Zixue, et al.
Publicado: (2023)

Editorial: The Immunomodulatory Roles of Adipocytes
por: Bradley, David, et al.
Publicado: (2021)

Editorial: Dendritic Cell-Based Immunotherapy in Solid and Haematologic Tumors
por: Dolcetti, Riccardo, et al.
Publicado: (2020)

Editorial: Next generation γδ T cell-based tumor immunotherapy
por: Tan, Andy Hee-Meng, et al.
Publicado: (2022)

Extracellular Vesicles in Hepatobiliary Malignancies
por: Lapitz, Ainhoa, et al.
Publicado: (2018)

Irreversible Electroporation: An Emerging Immunomodulatory Therapy on Solid Tumors
por: Zhang, Nana, et al.
Publicado: (2022)

Immunomodulatory Monoclonal Antibodies in Combined Immunotherapy Trials for Cutaneous Melanoma
por: Aris, Mariana, et al.
Publicado: (2017)

Editorial: Immunomodulatory Functions of Nutritional Ingredients in Health and Disease
por: Sun, Jia, et al.
Publicado: (2019)

Editorial: Immunomodulatory Roles of Tryptophan Metabolites in Inflammation and Cancer
por: Günther, Juliane, et al.
Publicado: (2020)

Editorial: Extracellular Vesicles as Immunomodulatory Mediators in Inflammatory Processes
por: Donate, Paula Barbim, et al.
Publicado: (2022)

Editorial: Immunomodulatory Roles of Extracellular Vesicles in Autoimmune Diseases
por: Gu, Zhifeng, et al.
Publicado: (2022)

Editorial: Immunomodulatory role of metalloproteases in chronic inflammatory diseases
por: Yang, Guan-Jun, et al.
Publicado: (2023)

The State of Immunotherapy in Hepatobiliary Cancers
por: Ilyas, Farhan Z., et al.
Publicado: (2021)

Tumor immunomodulatory effects of polyphenols
por: Wang, Qin, et al.
Publicado: (2022)

Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer Immunotherapy
por: Kersten, Kelly, et al.
Publicado: (2015)

Adjuvanted Immunotherapy Approaches for Peanut Allergy
por: Johnson-Weaver, Brandi T., et al.
Publicado: (2018)

Editorial: Immunomodulatory Effects of Drugs for Treatment of Immune-Related Diseases
por: Maghazachi, Azzam A.
Publicado: (2017)

Postoperative adjuvant tyrosine kinase inhibitors combined with anti-PD-1 antibodies improves surgical outcomes for hepatocellular carcinoma with high-risk recurrent factors
por: Li, Jian, et al.
Publicado: (2023)

Editorial: The role of multi-omics variants in tumor immunity and immunotherapy
por: Chen, Shuang, et al.
Publicado: (2022)

Editorial: NK Cell-Based Cancer Immunotherapy
por: Borrego, Francisco, et al.
Publicado: (2016)

Editorial: Nanobody-based cancer immunotherapy and immunoimaging
por: Jafari, Mahdie, et al.
Publicado: (2023)

Immunomodulatory roles of selenium nanoparticles: Novel arts for potential immunotherapy strategy development
por: Chen, Gengshi, et al.
Publicado: (2022)

Advances in Targeted Immunotherapy for Hepatobiliary Cancers
por: Ruff, Samantha M., et al.
Publicado: (2022)

Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
por: Yang, Chang, et al.
Publicado: (2020)

Editorial: Tumor microenvironment, immunotherapy, and drug resistance in breast and gastrointestinal cancer
por: Deng, Xinpei, et al.
Publicado: (2023)

Versican enrichment predicts poor prognosis and response to adjuvant therapy and immunotherapy in gastric cancer
por: Song, Junquan, et al.
Publicado: (2022)

Targeting tumor-associated macrophage: an adjuvant strategy for lung cancer therapy
por: Liu, Lei, et al.
Publicado: (2023)

Editorial: Immunotherapy in Multiple Myeloma
por: Giuliani, Nicola, et al.
Publicado: (2019)

Immunomodulatory properties of the lymphatic endothelium in the tumor microenvironment
por: Viúdez-Pareja, Cristina, et al.
Publicado: (2023)

Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
por: Kirtland, Max E., et al.
Publicado: (2020)

Editorial: Targeting the Tumor Microenvironment for a More Effective and Efficient Cancer Immunotherapy
por: Chouaib, Salem, et al.
Publicado: (2020)

Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy
por: Wennerberg, Erik, et al.
Publicado: (2021)

Editorial: Biomarkers in the era of cancer immunotherapy: zooming in from the periphery to the tumor microenvironment
por: Charo, Jehad, et al.
Publicado: (2023)

Immunomodulatory Properties of Bacterium-Like Particles Obtained From Immunobiotic Lactobacilli: Prospects for Their Use as Mucosal Adjuvants
por: Raya Tonetti, Fernanda, et al.
Publicado: (2020)

Postoperative adjuvant therapy for hepatocellular carcinoma with microvascular invasion
por: Li, Jiang, et al.
Publicado: (2023)

Editorial: The Microbiome in Hepatobiliary and Intestinal Disease
por: Hartmann, Phillipp
Publicado: (2022)

Anti-oxidative Amino Acid L-ergothioneine Modulates the Tumor Microenvironment to Facilitate Adjuvant Vaccine Immunotherapy
por: Yoshida, Sumito, et al.
Publicado: (2019)

Interleukin-6 and indoleamine-2,3-dioxygenase as potential adjuvant targets for Papillomavirus-related tumors immunotherapy
por: Pagni, Roberta Liberato, et al.
Publicado: (2022)

Editorial: Peptide-based immunotherapy against emerging viral infections
por: Jiang, Shisong
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s29frr0js9ru6kg04jqnvb8t57